期刊文献+

鼻型结外NK/T细胞淋巴瘤患者外周血CD4^+CD25^+调节性T细胞检测的临床意义 被引量:3

Clinical significance of peripheral blood CD4^+CD25^+ regulatory T cell in patients with extranodal NK/T cell lymphoma, nasal type
原文传递
导出
摘要 目的 通过检测鼻型结外NK/T细胞淋巴瘤(ENKL)患者外周血调节性T细胞(Treg细胞),探讨外周血Treg细胞与ENKL的关系.方法 选取北京同仁医院血液科2009年3月至2012年12月收治的41例初治ENKL患者,20名健康志愿者作为正常对照.采用流式细胞仪联合标记检测外周血Treg(CD4+CD25+)细胞,并与淋巴瘤危险因素及疗效、预后等进行相关性分析.结果 ENKL患者治疗前外周血Treg细胞比例为(9.64±4.96)%,高于正常对照组的(7.31±3.02)%,差异具有统计学意义(P<0.05);治疗后患者外周血Treg细胞降至(5.18±2.19)%,与治疗前比较差异具有统计学意义(P<0.01);Treg细胞比例在治疗有效组(35例)和治疗无效组(6例)分别为(8.79±4.15)%和(14.57±6.73)%,两者差异具有统计学意义(P< 0.05).ENKL患者Treg细胞比例与血清LDH水平呈正相关;Treg细胞比例正常组患者的总生存率和无进展生存率高于Treg细胞比例增高组,但差异无统计学意义.结论 ENKL患者外周血Treg细胞与疗效及血清LDH水平相关,可能对ENKL的疗效及预后有一定的预测作用. Objective To investigate the clinical significance of peripheral blood regulatory T cell (Treg) population in patients with extranodal NK/T cell lymphoma,nasal type (ENKL).Methods The peripheral blood CD4+CD25+ Treg cell population was detected by flow cytometry in 41 newly diagnosed ENKL patients between March 2009 and December 2012.Results The proportion of CD4+CD25+ Treg cell population increased in ENKL patients compared to healthy donors [(9.64±4.96) % vs (7.31 ± 3.02) %,P<0.05],and decreased significantly after treatment [(5.18 ±2.19) %,P<0.01].Patients when got response had significantly lower proportion of Treg cells [(8.79±4.15)%] as compared with those without response [(14.57±6.73)%,P<0.05].The proportion of Treg population was positively related to the serum lactate dehydrogenass level.Conclusions The proportion of peripheral blood Treg cells may be helpful for predicting prognosis and therapeutic efficacy in ENKL patients.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2014年第9期808-811,共4页 Chinese Journal of Hematology
基金 北京市科委首都市民健康项目培育(Z111107067311070) 鼻病研究北京市重点实验室资助项目(2014BBYJ05)
关键词 淋巴瘤 结外NK-T细胞 T淋巴细胞 调节性 预后 Lymphoma, extranodal NK-T-cell T-lymphocytes, regulatory Prognosis
  • 相关文献

参考文献15

  • 1Au WY.Current management of nasal NK/T-cell lymphoma[J].Oncology,2010,24(4):352-358.
  • 2Kwong YL.The diagnosis and management ofextranodal NK/T-cell lymphoma,nasal-type and aggressive NK-cell leukemia[J].J Clin Exp Hematop,2011,51 (1):21-28.
  • 3Yamagami W,Susumu N,Tanaka H,et al.Immunofluorescencedetected infiltration of CD4-POXP3-regulatory T cells is relevant to the prognosis of patients with endometrial cancer[J].Int J Gynecol Cancer,2011,21 (9):1628-1634.
  • 4Xu D,Wang FS.Are non-traditional CD4(+)CD69(+)CD25(-) regulatory T cells involved in disease progression of human hepatocellular carcinoma?[J].J Gastroenterol Hepatol,2011,26(10):1469-1470.
  • 5Mittal S,Marshall NA,Duncan L,et al.Local and systemic induction of CD4+CD25+ regulation T-cell population by non-Hodgkin lymphoma[J].Blood,2008,111 (11):5359-5370.
  • 6李丽娟,王晶,景红梅,胡小舟,王小林,克晓燕.CD4^+CD25^+CD127^(low)调节T细胞在非霍奇金淋巴瘤中的表达[J].医学研究杂志,2010,39(3):81-85. 被引量:3
  • 7Swerdlow SH,Campo E,Harris NL,et al.WHO Classification of tumours of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2008:14-15.
  • 8Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25).Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J].J Immunol,1995,155(3):1151-1164.
  • 9Wing K,Sakaguchi S.Regulatory T cells exert checks and balances on self tolerance and autoimmunity[J].Nat Immunol,2010,11(1):7-13.
  • 10Loser K,Beissert S.Regulatory T cells:banned cells for decades[J].J Invest Dermatol,2012,132(3 Pt 2):864-871.

二级参考文献20

  • 1王德林,朱军.恶性淋巴瘤的血清肿瘤标志[J].白血病.淋巴瘤,2005,14(6):335-338. 被引量:8
  • 2吴鹏强,赵春燕,韩丽英.淋巴瘤患者血清乳酸脱氢酶检测的临床意义[J].泸州医学院学报,2006,29(1):22-23. 被引量:10
  • 3刘莉,姚军霞,丁乾,黄士昂.非霍奇金淋巴瘤患者外周血CD4^+CD25^(high)调节性T细胞研究[J].中国实验血液学杂志,2006,14(1):119-122. 被引量:30
  • 4Itoh M,Takahashi T,Sakaguchi N,et al.Thymus and autoimmunity:production of CD25 * CD4 * naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self tolerance.J Immunol,1999,162 (9):5317-5326.
  • 5Beissert S,Schwarz A,Schwarz T.Regulatory T cells[J].J Invest Dermatol,2006,126 (1):15-24.
  • 6Von Boehmer H.Mechanisms of suppression by suppressor T cells.Nat Immunol,2005,6 (4):338-344.
  • 7Pyzik M,Piccirillo CA.TGF-betal modulates Foxp3 expression and regulatory activity in distinct CD4 * T cell subsets'.J Leukoc Biol,2007,82 (2):335-346.
  • 8Liu WH,Putnam AL,Xu-Yu Z,et al.CD127 expression inversely correlates with Foxp3 and suppressive function of human CD4 + Treg cells.J Exp Med,2006,203; 1701-1711.
  • 9Beissert S,Schwarz A,Schwarz T.Regulatory T cells[J].J Invest Dermatol,2006,126 (1):15-24.
  • 10Pyzik M,Piccirillo CA.TCF-betal modulates Foxp3 expression and regulatory activity in distinct CD4 * T cell subsets'.J Leukoc Biol,2007,82 (2):335-346.

共引文献4

同被引文献10

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部